Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Mirati Therapeutics Net Income 2006-2020 | MRTX

Mirati Therapeutics annual/quarterly net income history and growth rate from 2006 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Mirati Therapeutics net income for the quarter ending June 30, 2020 was $-0.083B, a 81.33% increase year-over-year.
  • Mirati Therapeutics net income for the twelve months ending June 30, 2020 was $-0.296B, a 107.91% increase year-over-year.
  • Mirati Therapeutics annual net income for 2019 was $-0.213B, a 116.68% increase from 2018.
  • Mirati Therapeutics annual net income for 2018 was $-0.098B, a 39.74% increase from 2017.
  • Mirati Therapeutics annual net income for 2017 was $-0.07B, a 15.27% decline from 2016.
  
Mirati Therapeutics Annual Net Income
(Millions of US $)
2019 $-213
2018 $-98
2017 $-70
2016 $-83
2015 $-65
2014 $-44
2013 $-53
2012 $-20
2011 $-10
2010 $-14
2009 $-21
2008 $-8
2007 $-21
2006 $-7
2005 $-13
Mirati Therapeutics Quarterly Net Income
(Millions of US $)
2020-06-30 $-83
2020-03-31 $-87
2019-12-31 $-72
2019-09-30 $-54
2019-06-30 $-46
2019-03-31 $-41
2018-12-31 $-28
2018-09-30 $-28
2018-06-30 $-28
2018-03-31 $-15
2017-12-31 $-18
2017-09-30 $-16
2017-06-30 $-18
2017-03-31 $-18
2016-12-31 $-20
2016-09-30 $-19
2016-06-30 $-22
2016-03-31 $-22
2015-12-31 $-18
2015-09-30 $-19
2015-06-30 $-15
2015-03-31 $-12
2014-12-31 $-10
2014-09-30 $-9
2014-06-30 $-11
2014-03-31 $-14
2013-12-31 $-11
2013-09-30 $-29
2013-06-30 $-8
2013-03-31 $-4
2012-12-31 $-6
2012-09-30 $-6
2012-06-30 $-5
2012-03-31 $-3
2011-12-31 $-4
2011-09-30 $-3
2011-06-30 $-1
2011-03-31 $-2
2010-12-31 $-2
2010-09-30 $-5
2010-06-30 $-3
2010-03-31 $-4
2009-12-31 $-5
2009-09-30 $-5
2009-06-30 $-6
2009-03-31 $-5
2008-12-31 $7
2008-09-30 $-3
2008-06-30 $-7
2008-03-31 $-5
2007-12-31 $-7
2007-09-30 $-5
2007-06-30 $-6
2007-03-31 $-3
2006-12-31 $-2
2006-09-30 $3
2006-06-30 $-4
2006-03-31 $-4
2005-12-31 $-4
2005-09-30 $-3
2005-06-30 $-3
2005-03-31 $-2
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $7.241B $0.003B
Mirati Therapeutics, Inc. is a biopharmaceutical company. It engaged in the development of novel therapeutics for the treatment of cancer. Mirati Therapeutics, Inc., formerly known as MethylGene Inc., is based in Montreal, Canada.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $145.111B 15.76
Bristol Myers Squibb (BMY) United States $134.517B 10.36
CSL (CSLLY) Australia $96.728B 0.00
Gilead Sciences (GILD) United States $82.307B 11.85
Vertex Pharmaceuticals (VRTX) United States $69.688B 38.89
Regeneron Pharmaceuticals (REGN) United States $60.553B 23.16
Illumina (ILMN) United States $47.081B 54.75
Biogen (BIIB) United States $43.756B 7.49
Seattle Genetics (SGEN) United States $30.731B 0.00
Moderna (MRNA) United States $27.163B 0.00
Alexion Pharmaceuticals (ALXN) United States $25.549B 10.65
Genmab (GMAB) Denmark $24.398B 15.41
Genmab (GNMSF) Denmark $23.229B 5.35
BeiGene (BGNE) Cayman Islands $22.973B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $21.904B 0.00
Immunomedics (IMMU) United States $19.730B 0.00
Incyte (INCY) United States $19.670B 0.00
Horizon Therapeutics Public (HZNP) Ireland $16.061B 37.58
Alnylam Pharmaceuticals (ALNY) United States $15.225B 0.00
BioNTech SE (BNTX) Germany $14.942B 0.00
Bio-Rad Laboratories (BIO.B) United States $14.252B 64.46
BioMarin Pharmaceutical (BMRN) United States $13.717B 99.53
Exact Sciences (EXAS) United States $11.414B 0.00
QIAGEN (QGEN) Netherlands $11.410B 28.96
Sarepta Therapeutics (SRPT) United States $11.301B 0.00
ARGENX SE-ADR (ARGX) Netherlands $11.250B 0.00
Guardant Health (GH) United States $10.231B 0.00
Bio-Techne Corp (TECH) United States $9.431B 64.71
Galapagos (GLPG) Belgium $8.943B 32.40
Exelixis (EXEL) United States $8.229B 29.92
Repligen (RGEN) United States $7.726B 122.63
Ascendis Pharma (ASND) Denmark $7.664B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $7.424B 18.47
Novavax (NVAX) United States $7.361B 0.00
MyoKardia (MYOK) United States $6.913B 0.00
Momenta Pharmaceuticals (MNTA) United States $6.234B 0.00
Adaptive Biotechnologies (ADPT) United States $6.211B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.181B 0.00
Acceleron Pharma (XLRN) United States $6.063B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.009B 186.15
Emergent Biosolutions (EBS) United States $5.416B 21.45
Ultragenyx Pharmaceutical (RARE) United States $4.993B 0.00
Zai Lab (ZLAB) China $4.800B 0.00
MorphoSys AG (MOR) Germany $4.363B 57.17
China Biologic Products (CBPO) China $4.322B 25.66
Blueprint Medicines (BPMC) United States $4.200B 0.00
Legend Biotech (LEGN) United States $4.193B 0.00
Vir Biotechnology (VIR) United States $4.188B 0.00
Denali Therapeutics (DNLI) United States $4.054B 0.00
Arena Pharmaceuticals (ARNA) United States $4.030B 0.00
NeoGenomics (NEO) United States $3.917B 1182.33
Halozyme Therapeutics (HALO) United States $3.831B 0.00
Bluebird Bio (BLUE) United States $3.619B 0.00
Amicus Therapeutics (FOLD) United States $3.618B 0.00
Reata Pharmaceuticals (RETA) United States $3.536B 0.00
Insmed (INSM) United States $3.501B 0.00
Global Blood Therapeutics (GBT) United States $3.360B 0.00
Principia Biopharma (PRNB) United States $3.321B 0.00
Fate Therapeutics (FATE) United States $3.207B 0.00
Inovio Pharmaceuticals (INO) United States $3.102B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.912B 0.00
Alkermes (ALKS) Ireland $2.844B 59.60
Twist Bioscience (TWST) United States $2.812B 0.00
Revance Therapeutics (RVNC) United States $2.261B 0.00
PHARMA MAR SA (PHMMF) Spain $2.214B 0.00
Mesoblast (MESO) Australia $2.107B 0.00
I-Mab (IMAB) China $2.100B 0.00
Seres Therapeutics (MCRB) United States $2.084B 0.00
Editas Medicine (EDIT) United States $2.069B 0.00
Intra-Cellular Therapies (ITCI) United States $2.068B 0.00
Sorrento Therapeutics (SRNE) United States $2.023B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.006B 22.47
Eidos Therapeutics (EIDX) United States $1.897B 0.00
Zymeworks (ZYME) Canada $1.894B 0.00
UniQure (QURE) Netherlands $1.878B 0.00
Viela Bio (VIE) United States $1.851B 0.00
Akcea Therapeutics (AKCA) United States $1.843B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.842B 0.00
Mersana Therapeutics (MRSN) United States $1.758B 0.00
Amarin (AMRN) Ireland $1.611B 0.00
Cytokineticsorporated (CYTK) United States $1.571B 0.00
Ligand Pharmaceuticals (LGND) United States $1.530B 51.73
Sangamo Therapeutics (SGMO) United States $1.494B 0.00
Beam Therapeutics (BEAM) United States $1.489B 0.00
Zealand Pharma (ZEAL) Denmark $1.463B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.457B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.434B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.403B 0.00
Arcus Biosciences (RCUS) United States $1.402B 0.00
Coherus BioSciences (CHRS) United States $1.353B 7.89
Intellia Therapeutics (NTLA) United States $1.349B 0.00
Zealand Pharma (ZLDPF) Denmark $1.339B 0.00
NGM Biopharmaceuticals (NGM) United States $1.323B 0.00
Epizyme (EPZM) United States $1.295B 0.00
Compugen (CGEN) Israel $1.223B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.134B 0.00
Alector (ALEC) United States $1.121B 0.00
REGENXBIO (RGNX) United States $1.112B 0.00
Alcobra (ARCT) United States $1.093B 0.00
Arvinas (ARVN) United States $1.073B 0.00
Athenex (ATNX) United States $1.067B 0.00
Adverum Biotechnologies (ADVM) United States $1.036B 0.00
Retrophin (RTRX) United States $1.013B 0.00
Myriad Genetics (MYGN) United States $0.974B 0.00
Pliant Therapeutics (PLRX) United States $0.973B 0.00
Castle Biosciences (CSTL) United States $0.946B 0.00
Agenus (AGEN) United States $0.937B 0.00
Heska (HSKA) United States $0.926B 0.00
Intrexon (PGEN) United States $0.893B 0.00
NantKwest (NK) United States $0.886B 0.00
Morphic Holding (MORF) United States $0.870B 0.00
VBI Vaccines (VBIV) United States $0.869B 0.00
Cellectis S.A (CLLS) France $0.861B 0.00
Vericel (VCEL) United States $0.857B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.846B 0.00
Frequency Therapeutics (FREQ) United States $0.820B 0.00
Protagonist Therapeutics (PTGX) United States $0.778B 0.00
Kadmon Holdings (KDMN) United States $0.772B 0.00
Pharming Group (PHGUF) Netherlands $0.751B 17.14
Codexis (CDXS) United States $0.729B 0.00
MiMedx (MDXG) United States $0.710B 0.00
Cara Therapeutics (CARA) United States $0.708B 0.00
Northwest Biotherapeutics (NWBO) United States $0.695B 0.00
Clovis Oncology (CLVS) United States $0.680B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.674B 0.00
WAVE Life Sciences (WVE) Singapore $0.646B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
AC Immune SA (ACIU) Switzerland $0.634B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.627B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.627B 0.00
Albireo Pharma (ALBO) United States $0.597B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.596B 0.00
Dynavax Technologies (DVAX) United States $0.592B 0.00
Geron (GERN) United States $0.562B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.557B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.530B 4.64
Anika Therapeutics (ANIK) United States $0.527B 23.03
Scholar Rock Holding (SRRK) United States $0.522B 0.00
IVERIC Bio (ISEE) United States $0.522B 0.00
Cue Biopharma (CUE) United States $0.519B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.511B 0.00
MeiraGTx Holdings (MGTX) United States $0.509B 0.00
Cel-Sci (CVM) United States $0.494B 0.00
Forte Biosciences (FBRX) United States $0.490B 0.00
Kala Pharmaceuticals (KALA) United States $0.483B 0.00
UROGEN PHARMA (URGN) United States $0.468B 0.00
Syros Pharmaceuticals (SYRS) United States $0.463B 0.00
Celldex Therapeutics (CLDX) United States $0.459B 0.00
Starpharma Holdings (SPHRY) Australia $0.455B 0.00
Amryt Pharma (AMYT) United Kingdom $0.443B 0.00
Avid Bioservices (CDMO) United States $0.442B 0.00
MannKind (MNKD) United States $0.438B 0.00
Pfenex (PFNX) United States $0.435B 0.00
Prothena (PRTA) Ireland $0.433B 0.00
AnaptysBio (ANAB) United States $0.430B 0.00
Athersys (ATHX) United States $0.422B 0.00
BioDelivery Sciences (BDSI) United States $0.405B 28.64
Puma Biotechnology (PBYI) United States $0.398B 0.00
Sutro Biopharma (STRO) United States $0.395B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.391B 0.00
Fortress Biotech (FBIO) United States $0.388B 0.00
Kamada (KMDA) Israel $0.387B 18.49
PDL BioPharma (PDLI) United States $0.375B 0.00
IBio (IBIO) United States $0.375B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.366B 0.00
ANI Pharmaceuticals (ANIP) United States $0.363B 8.57
Cellular Biomedicine (CBMG) United States $0.359B 0.00
Merus (MRUS) Netherlands $0.345B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.342B 0.00
CytomX Therapeutics (CTMX) United States $0.339B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.336B 0.00
Innate Pharma S.A (IPHA) France $0.328B 0.00
Precision BioSciences (DTIL) United States $0.310B 0.00
Prometic Life Sciences (LMNL) Canada $0.297B 0.00
Trevena (TRVN) United States $0.292B 0.00
Menlo Therapeutics (VYNE) United States $0.288B 0.00
Selecta Biosciences (SELB) United States $0.281B 0.00
ChromaDex (CDXC) United States $0.279B 0.00
Affimed (AFMD) Germany $0.271B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.265B 0.00
Cyclerion Therapeutics (CYCN) United States $0.264B 0.00
OSMOTICA PHARM (OSMT) United States $0.258B 0.00
Checkpoint Therapeutics (CKPT) United States $0.255B 0.00
NextCure (NXTC) United States $0.252B 0.00
Pluristem Therapeutics (PSTI) Israel $0.252B 0.00
HOOKIPA Pharma (HOOK) United States $0.243B 0.00
Arbutus Biopharma (ABUS) United States $0.240B 0.00
Verastem (VSTM) United States $0.234B 0.00
TELA Bio (TELA) United States $0.232B 0.00
XOMA (XOMA) United States $0.227B 0.00
Liquidia Technologies (LQDA) United States $0.224B 0.00
DBV Technologies S.A (DBVT) France $0.220B 0.00
Dyadic (DYAI) United States $0.214B 0.00
Aduro Biotech (ADRO) United States $0.212B 0.00
Spero Therapeutics (SPRO) United States $0.211B 0.00
ADMA Biologics Inc (ADMA) United States $0.207B 0.00
Kindred Biosciences (KIN) United States $0.200B 0.00
Cerecor (CERC) United States $0.200B 0.00
Biofrontera AG (BFRA) Germany $0.194B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
GENFIT S.A (GNFT) France $0.179B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.179B 0.00
Theratechnologies (THTX) Canada $0.179B 0.00
Exicure (XCUR) United States $0.178B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.178B 8.30
Aptinyx (APTX) United States $0.162B 0.00
Eton Pharmaceuticals (ETON) United States $0.161B 0.00
Abeona Therapeutics (ABEO) United States $0.160B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.159B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.157B 0.00
VolitionRX (VNRX) United States $0.153B 0.00
Strongbridge Biopharma (SBBP) United States $0.152B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.151B 0.00
Aytu Bioscience (AYTU) United States $0.151B 0.00
Five Prime Therapeutics (FPRX) United States $0.146B 0.00
Nicox SA (NICXF) France $0.146B 0.00
VTv Therapeutics (VTVT) United States $0.145B 0.00
CorMedix Inc (CRMD) United States $0.143B 0.00
Bellus Health (BLU) Canada $0.142B 0.00
Celyad SA (CYAD) Belgium $0.141B 0.00
Cidara Therapeutics (CDTX) United States $0.139B 0.00
Cardiff Oncology (CRDF) United States $0.135B 0.00
AquaBounty Technologies (AQB) United States $0.134B 0.00
Applied Genetic Technologies (AGTC) United States $0.131B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.129B 0.00
SESEN BIO, INC (SESN) United States $0.125B 0.00
Gritstone Oncology (GRTS) United States $0.124B 0.00
Lumos Pharma (LUMO) United States $0.122B 0.00
Palatin Technologies (PTN) United States $0.116B 2.98
Windtree Therapeutics (WINT) United States $0.115B 0.00
Protalix BioTherapeutics (PLX) Israel $0.115B 0.00
Enzo Biochem (ENZ) United States $0.111B 0.00
Antibe Therapeutics (ATBPF) Canada $0.111B 0.00
Catalyst Biosciences (CBIO) United States $0.109B 0.00
Unum Therapeutics (UMRX) United States $0.108B 0.00
Vaccinex (VCNX) United States $0.106B 0.00
Orgenesis (ORGS) United States $0.105B 5.34
PHASEBIO PHARMA (PHAS) United States $0.102B 0.00
ARAVIVE, INC (ARAV) United States $0.098B 0.00
AIT Therapeutics (XAIR) United States $0.093B 0.00
Idera Pharmaceuticals (IDRA) United States $0.087B 0.00
Oncobiologics (OTLK) United States $0.086B 0.00
DiaMedica Therapeutics (DMAC) United States $0.083B 0.00
Bionano Genomics (BNGO) United States $0.082B 0.00
Adocia (ADOCY) France $0.080B 0.00
Clearside Biomedical (CLSD) United States $0.077B 0.00
Synlogic (SYBX) United States $0.077B 0.00
Ecology Coatings (ABVC) United States $0.072B 0.00
Edesa Biotech (EDSA) Canada $0.071B 0.00
AmpliPhi Biosciences (ARMP) United States $0.068B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.067B 0.00
Proteostasis Therapeutics (PTI) United States $0.067B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.066B 0.00
Evogene (EVGN) Israel $0.064B 0.00
Prima BioMed (IMMP) Australia $0.062B 0.00
TRACON Pharmaceuticals (TCON) United States $0.062B 0.00
Curis (CRIS) United States $0.060B 0.00
Soligenix (SNGX) United States $0.059B 0.00
Emmaus Life Sciences (EMMA) United States $0.057B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.057B 0.00
Vascular Biogenics (VBLT) Israel $0.057B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.055B 0.00
AnPac Bio-Medical Science (ANPC) China $0.055B 0.00
Stealth BioTherapeutics (MITO) United States $0.053B 75.50
Genetic Technologies (GENE) Australia $0.052B 0.00
Appili Therapeutics (APLIF) Canada $0.052B 0.00
Cocrystal Pharma (COCP) United States $0.052B 0.00
Novogen (KZIA) Australia $0.051B 0.00
Organovo Holdings (ONVO) United States $0.051B 0.00
Happiness Biotech Group (HAPP) China $0.050B 0.00
CollPlant Holdings (CLGN) Israel $0.050B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.048B 0.00
Signal Genetics (MGEN) United States $0.048B 0.00
IMMURON (IMRN) Australia $0.046B 0.00
Pulmatrix (PULM) United States $0.043B 0.00
ATyr Pharma (LIFE) United States $0.040B 0.00
Chanticleer Holdings (SONN) United States $0.034B 0.00
OvaScience (MLND) United States $0.032B 0.00
Prana Biotechnology (ATHE) Australia $0.030B 0.00
Apricus Biosciences (SEEL) United States $0.029B 0.00
Advaxis (ADXS) United States $0.029B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Cleveland BioLabs (CBLI) United States $0.029B 0.00
Alimera Sciences (ALIM) United States $0.028B 0.00
Acorda Therapeutics (ACOR) United States $0.026B 0.00
Celsion (CLSN) United States $0.026B 0.00
Aptevo Therapeutics (APVO) United States $0.026B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.026B 0.00
Cesca Therapeutics (THMO) United States $0.024B 0.00
Spherix (AIKI) United States $0.020B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
MYOS RENS Technology (MYOS) United States $0.017B 0.00
BioPharmX (TMBR) United States $0.012B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00